{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:53:24Z","timestamp":1795085604856,"version":"4.10.2"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T00:00:00Z","timestamp":1740009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["Z-2014-08-2309-3"],"award-info":[{"award-number":["Z-2014-08-2309-3"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wenzhou Major Science and Technology Innovation Projects","award":["ZY2022014"],"award-info":[{"award-number":["ZY2022014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01621-6","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:41:41Z","timestamp":1740030101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":143,"title":["Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation"],"prefix":"10.1186","volume":"18","author":[{"given":"Pingping","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,20]]},"reference":[{"key":"1621_CR1","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10:668\u201380. https:\/\/doi.org\/10.1016\/S2213-8587(22)00163-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1621_CR2","doi-asserted-by":"publisher","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","volume":"106","author":"KM Hoeger","year":"2021","unstructured":"Hoeger KM, Dokras A, Piltonen T. Update on PCOS: consequences, challenges, and Guiding Treatment. J Clin Endocrinol Metab. 2021;106:e1071\u201383. https:\/\/doi.org\/10.1210\/clinem\/dgaa839.","journal-title":"J Clin Endocrinol Metab"},{"key":"1621_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","volume":"29","author":"IF Stein","year":"1935","unstructured":"Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol. 1935;29:181\u201391.","journal-title":"Am J Obstet Gynecol"},{"key":"1621_CR4","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1002\/cphy.c210025","volume":"12","author":"MSB Silva","year":"2022","unstructured":"Silva MSB, Campbell RE. Polycystic ovary syndrome and the neuroendocrine consequences of androgen excess. Compr Physiol. 2022;12:3347\u201369. https:\/\/doi.org\/10.1002\/cphy.c210025.","journal-title":"Compr Physiol"},{"key":"1621_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","volume":"7","author":"MO Goodarzi","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219\u201331. https:\/\/doi.org\/10.1038\/nrendo.2010.217.","journal-title":"Nat Rev Endocrinol"},{"key":"1621_CR6","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, et al. Chronic low Grade inflammation in Pathogenesis of PCOS. Int J Mol Sci. 2021;22:3789. https:\/\/doi.org\/10.3390\/ijms22073789.","journal-title":"Int J Mol Sci"},{"key":"1621_CR7","doi-asserted-by":"publisher","first-page":"174550572211179","DOI":"10.1177\/17455057221117966","volume":"18","author":"H Islam","year":"2022","unstructured":"Islam H, Masud J, Islam YN, Haque FKM. An update on polycystic ovary syndrome: a review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options. Womens Health (Lond). 2022;18:17455057221117966. https:\/\/doi.org\/10.1177\/17455057221117966.","journal-title":"Womens Health (Lond)"},{"key":"1621_CR8","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057. https:\/\/doi.org\/10.1038\/nrdp.2016.57.","journal-title":"Nat Rev Dis Primers"},{"key":"1621_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2217\/17455057.4.6.583","volume":"4","author":"CD Christakou","year":"2008","unstructured":"Christakou CD, Diamanti-Kandarakis E. Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome. Womens Health (Lond). 2008;4:583\u201394. https:\/\/doi.org\/10.2217\/17455057.4.6.583.","journal-title":"Womens Health (Lond)"},{"key":"1621_CR10","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00125-022-05746-x","volume":"65","author":"Q Liu","year":"2022","unstructured":"Liu Q, Tang B, Zhu Z, Kraft P, Deng Q, Stener-Victorin E, et al. A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome. Diabetologia. 2022;65:1483\u201394. https:\/\/doi.org\/10.1007\/s00125-022-05746-x.","journal-title":"Diabetologia"},{"key":"1621_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/biomedicines7010005","volume":"7","author":"S Mikhael","year":"2019","unstructured":"Mikhael S, Punjala-Patel A, Gavrilova-Jordan L. Hypothalamic-pituitary-ovarian Axis disorders Impacting Female Fertility. Biomedicines. 2019;7:5. https:\/\/doi.org\/10.3390\/biomedicines7010005.","journal-title":"Biomedicines"},{"key":"1621_CR12","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1210\/er.2009-0023","volume":"31","author":"CA Christian","year":"2010","unstructured":"Christian CA, Moenter SM. The neurobiology of preovulatory and estradiol-induced gonadotropin-releasing hormone surges. Endocr Rev. 2010;31:544\u201377. https:\/\/doi.org\/10.1210\/er.2009-0023.","journal-title":"Endocr Rev"},{"issue":"Suppl 2","key":"1621_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/humrep\/8.suppl_2.57","volume":"8","author":"JC Marshall","year":"1993","unstructured":"Marshall JC, Griffin ML. The role of changing pulse frequency in the regulation of ovulation. Hum Reprod. 1993;8(Suppl 2):57\u201361. https:\/\/doi.org\/10.1093\/humrep\/8.suppl_2.57.","journal-title":"Hum Reprod"},{"key":"1621_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1126\/science.100883","volume":"202","author":"PE Belchetz","year":"1978","unstructured":"Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science. 1978;202:631\u20133. https:\/\/doi.org\/10.1126\/science.100883.","journal-title":"Science"},{"key":"1621_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.bpobgyn.2004.06.001","volume":"18","author":"ZM van der Spuy","year":"2004","unstructured":"van der Spuy ZM, Dyer SJ. The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18:755\u201371. https:\/\/doi.org\/10.1016\/j.bpobgyn.2004.06.001.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"1621_CR16","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1210\/jcem.82.7.4105","volume":"82","author":"AE Taylor","year":"1997","unstructured":"Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82:2248\u201356. https:\/\/doi.org\/10.1210\/jcem.82.7.4105.","journal-title":"J Clin Endocrinol Metab"},{"key":"1621_CR17","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1172\/JCI108400","volume":"57","author":"R Rebar","year":"1976","unstructured":"Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J Clin Invest. 1976;57:1320\u20139. https:\/\/doi.org\/10.1172\/JCI108400.","journal-title":"J Clin Invest"},{"key":"1621_CR18","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.fertnstert.2008.01.036","volume":"91","author":"MI Hsu","year":"2009","unstructured":"Hsu MI, Liou TH, Liang SJ, Su HW, Wu CH, Hsu CS. Inappropriate gonadotropin secretion in polycystic ovary syndrome. Fertil Steril. 2009;91:1168\u201374. https:\/\/doi.org\/10.1016\/j.fertnstert.2008.01.036.","journal-title":"Fertil Steril"},{"key":"1621_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3760\/cma.j.issn.0529-567x.2018.01.002","volume":"53","author":"Endocrinology Group and Guideline Expert Group of the Obstetrics and Gynecology Branch of the Chinese Medical Association Chinese Diagnosis and Treatment Guidelines for Polycystic Ovary Syndrome","year":"2018","unstructured":"Endocrinology Group and Guideline Expert Group of the Obstetrics and Gynecology Branch of the Chinese Medical Association Chinese Diagnosis and Treatment Guidelines for Polycystic Ovary Syndrome. Chin J Obstet Gynecol. 2018;53:2\u20136. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-567x.2018.01.002.","journal-title":"Chin J Obstet Gynecol"},{"key":"1621_CR20","first-page":"902","volume":"61","author":"The Japanese Society of Obstetrics and Gynecology (JSOG)","year":"2009","unstructured":"The Japanese Society of Obstetrics and Gynecology (JSOG). Constitute of reproductive endocrinology. Reports of a new treatment criteria of PCOS in Japan. Acta Obstet Gynecol Jpn. 2009;61:902\u201312.","journal-title":"Acta Obstet Gynecol Jpn"},{"key":"1621_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"ESHRE Rotterdam","year":"2004","unstructured":"Rotterdam ESHRE, ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41\u20137. https:\/\/doi.org\/10.1093\/humrep\/deh098.","journal-title":"Hum Reprod"},{"key":"1621_CR22","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/s0015-0282(97)81417-3","volume":"67","author":"ME Fallat","year":"1997","unstructured":"Fallat ME, Siow Y, Marra M, Cook C, Carrillo A. M\u00fcllerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis. Fertil Steril. 1997;67:962\u20135. https:\/\/doi.org\/10.1016\/s0015-0282(97)81417-3.","journal-title":"Fertil Steril"},{"key":"1621_CR23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1210\/jc.2005-2076","volume":"91","author":"P Pigny","year":"2006","unstructured":"Pigny P, Jonard S, Robert Y, Dewailly D. Serum anti-mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91:941\u20135. https:\/\/doi.org\/10.1210\/jc.2005-2076.","journal-title":"J Clin Endocrinol Metab"},{"key":"1621_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1210\/jc.2006-1582","volume":"92","author":"L Pellatt","year":"2007","unstructured":"Pellatt L, Hanna L, Brincat M, Galea R, Brain H, Whitehead S, et al. Granulosa cell production of anti-M\u00fcllerian hormone is increased in polycystic ovaries. J Clin Endocrinol Metab. 2007;92:240\u20135. https:\/\/doi.org\/10.1210\/jc.2006-1582.","journal-title":"J Clin Endocrinol Metab"},{"key":"1621_CR25","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1093\/humrep\/deq088","volume":"25","author":"FR Tehrani","year":"2010","unstructured":"Tehrani FR, Solaymani-Dodaran M, Hedayati M, Azizi F. Is polycystic ovary syndrome an exception for reproductive aging? Hum Reprod. 2010;25:1775\u201381. https:\/\/doi.org\/10.1093\/humrep\/deq088.","journal-title":"Hum Reprod"},{"key":"1621_CR26","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/humrep\/det015","volume":"28","author":"R Homburg","year":"2013","unstructured":"Homburg R, Ray A, Bhide P, Gudi A, Shah A, Timms P, et al. The relationship of serum anti-mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study. Hum Reprod. 2013;28:1077\u201383. https:\/\/doi.org\/10.1093\/humrep\/det015.","journal-title":"Hum Reprod"},{"key":"1621_CR27","doi-asserted-by":"publisher","first-page":"10055","DOI":"10.1038\/ncomms10055","volume":"7","author":"I Cimino","year":"2016","unstructured":"Cimino I, Casoni F, Liu X, Messina A, Parkash J, Jamin SP, et al. Novel role for anti-M\u00fcllerian hormone in the regulation of GnRH neuron excitability and hormone secretion. Nat Commun. 2016;7:10055. https:\/\/doi.org\/10.1038\/ncomms10055.","journal-title":"Nat Commun"},{"key":"1621_CR28","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.fertnstert.2011.08.015","volume":"96","author":"L Pellatt","year":"2011","unstructured":"Pellatt L, Rice S, Dilaver N, Heshri A, Galea R, Brincat M, et al. Anti-M\u00fcllerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertil Steril. 2011;96:1246\u201351..e1.","journal-title":"Fertil Steril"},{"key":"1621_CR29","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","volume":"142","author":"AL Durlinger","year":"2001","unstructured":"Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, et al. Anti-M\u00fcllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology. 2001;142:4891\u20139. https:\/\/doi.org\/10.1210\/endo.142.11.8486.","journal-title":"Endocrinology"},{"key":"1621_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","volume":"120","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven J, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertil Steril. 2023;120:767\u201393. https:\/\/doi.org\/10.1016\/j.fertnstert.2023.07.025.","journal-title":"Fertil Steril"},{"key":"1621_CR31","doi-asserted-by":"publisher","first-page":"719050","DOI":"10.1155\/2014\/719050","volume":"2014","author":"J Rojas","year":"2014","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, Rojas M, Morillo J, Mej\u00edas J, et al. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014;2014:719050. https:\/\/doi.org\/10.1155\/2014\/719050.","journal-title":"Int J Reprod Med"},{"key":"1621_CR32","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s12020-014-0200-7","volume":"47","author":"S Livadas","year":"2014","unstructured":"Livadas S, Pappas C, Karachalios A, Marinakis E, Tolia N, Drakou M, et al. Prevalence and impact of hyperandrogenemia in 1,218 women with polycystic ovary syndrome. Endocrine. 2014;47:631\u20138. https:\/\/doi.org\/10.1007\/s12020-014-0200-7.","journal-title":"Endocrine"},{"key":"1621_CR33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jc.2003-031122","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, et al. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab. 2004;89:453\u201362. https:\/\/doi.org\/10.1210\/jc.2003-031122.","journal-title":"J Clin Endocrinol Metab"},{"key":"1621_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1093\/humupd\/dml017","volume":"12","author":"SK Blank","year":"2006","unstructured":"Blank SK, McCartney CR, Marshall JC. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome. Hum Reprod Update. 2006;12:351\u201361. https:\/\/doi.org\/10.1093\/humupd\/dml017.","journal-title":"Hum Reprod Update"},{"key":"1621_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1210\/en.2018-00675","volume":"160","author":"JMK Azhary","year":"2019","unstructured":"Azhary JMK, Harada M, Takahashi N, et al. Endoplasmic reticulum stress activated by Androgen enhances apoptosis of Granulosa cells via induction of death receptor 5 in PCOS. Endocrinology. 2019;160:119\u201332. https:\/\/doi.org\/10.1210\/en.2018-00675.","journal-title":"Endocrinology"},{"key":"1621_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1254312","volume":"345","author":"M Lu","year":"2014","unstructured":"Lu M, Lawrence DA, Marsters S, Acosta-Alvear D, Kimmig P, Mendez AS, et al. Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis. Science. 2014;345:98\u2013101. https:\/\/doi.org\/10.1126\/science.1254312.","journal-title":"Science"},{"key":"1621_CR37","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/ijms18040792","volume":"18","author":"E Guzel","year":"2017","unstructured":"Guzel E, Arlier S, Guzeloglu-Kayisli O, Tabak MS, Ekiz T, Semerci N, et al. Endoplasmic reticulum stress and homeostasis in Reproductive Physiology and Pathology. Int J Mol Sci. 2017;18:792. https:\/\/doi.org\/10.3390\/ijms18040792.","journal-title":"Int J Mol Sci"},{"key":"1621_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/molehr\/gaaa040","volume":"26","author":"I Takehara","year":"2020","unstructured":"Takehara I, Igarashi H, Kawagoe J, Matsuo K, Takahashi K, Nishi M, et al. Impact of endoplasmic reticulum stress on oocyte aging mechanisms. Mol Hum Reprod. 2020;26:567\u201375. https:\/\/doi.org\/10.1093\/molehr\/gaaa040.","journal-title":"Mol Hum Reprod"},{"key":"1621_CR39","doi-asserted-by":"publisher","first-page":"bqaa015","DOI":"10.1210\/endocr\/bqaa015","volume":"161","author":"JMK Azhary","year":"2020","unstructured":"Azhary JMK, Harada M, Kunitomi C, Kusamoto A, Takahashi N, Nose E, et al. Androgens increase Accumulation of Advanced Glycation End products in Granulosa cells by activating ER stress in PCOS. Endocrinology. 2020;161:bqaa015. https:\/\/doi.org\/10.1210\/endocr\/bqaa015.","journal-title":"Endocrinology"},{"key":"1621_CR40","doi-asserted-by":"publisher","first-page":"815968","DOI":"10.3389\/fendo.2022.815968","volume":"13","author":"B Liao","year":"2022","unstructured":"Liao B, Qi X, Yun C, Qiao J, Pang Y. Effects of Androgen excess-related metabolic disturbances on Granulosa cell function and Follicular Development. Front Endocrinol (Lausanne). 2022;13:815968. https:\/\/doi.org\/10.3389\/fendo.2022.815968.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1621_CR41","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.7150\/ijbs.21172","volume":"13","author":"Y Wu","year":"2017","unstructured":"Wu Y, Li Y, Liao X, Wang Z, Li R, Zou S, et al. Diabetes induces abnormal ovarian function via triggering apoptosis of Granulosa cells and suppressing ovarian angiogenesis. Int J Biol Sci. 2017;13:1297\u2013308. https:\/\/doi.org\/10.7150\/ijbs.21172.","journal-title":"Int J Biol Sci"},{"key":"1621_CR42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3109\/09513590.2015.1062862","volume":"31","author":"M Harada","year":"2015","unstructured":"Harada M, Nose E, Takahashi N, Hirota Y, Hirata T, Yoshino O, et al. Evidence of the activation of unfolded protein response in granulosa and cumulus cells during follicular growth and maturation. Gynecol Endocrinol. 2015;31:783\u20137. https:\/\/doi.org\/10.3109\/09513590.2015.1062862.","journal-title":"Gynecol Endocrinol"},{"key":"1621_CR43","doi-asserted-by":"publisher","first-page":"e12458","DOI":"10.1111\/jpi.12458","volume":"64","author":"HJ Park","year":"2018","unstructured":"Park HJ, Park JY, Kim JW, Yang SG, Jung JM, Kim MJ, et al. Melatonin improves the meiotic maturation of porcine oocytes by reducing endoplasmic reticulum stress during in vitro maturation. J Pineal Res. 2018;64:e12458. https:\/\/doi.org\/10.1111\/jpi.12458.","journal-title":"J Pineal Res"},{"key":"1621_CR44","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1080\/09513590.2018.1540567","volume":"35","author":"X Li","year":"2019","unstructured":"Li X, Qi J, Zhu Q, He Y, Wang Y, Lu Y, et al. The role of androgen in autophagy of granulosa cells from PCOS. Gynecol Endocrinol. 2019;35:669\u201372. https:\/\/doi.org\/10.1080\/09513590.2018.1540567.","journal-title":"Gynecol Endocrinol"},{"key":"1621_CR45","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/humrep\/deaa077","volume":"35","author":"J Jin","year":"2020","unstructured":"Jin J, Ma Y, Tong X, Yang W, Dai Y, Pan Y, et al. Metformin inhibits testosterone-induced endoplasmic reticulum stress in ovarian granulosa cells via inactivation of p38 MAPK. Hum Reprod. 2020;35:1145\u201358. https:\/\/doi.org\/10.1093\/humrep\/deaa077.","journal-title":"Hum Reprod"},{"key":"1621_CR46","doi-asserted-by":"publisher","first-page":"117955811987146","DOI":"10.1177\/1179558119871467","volume":"13","author":"C Raperport","year":"2019","unstructured":"Raperport C, Homburg R. The source of polycystic ovarian syndrome. Clin Med Insights Reprod Health. 2019;13:1179558119871467. https:\/\/doi.org\/10.1177\/1179558119871467.","journal-title":"Clin Med Insights Reprod Health"},{"key":"1621_CR47","first-page":"53","volume":"36","author":"K Szosland","year":"2015","unstructured":"Szosland K, Pawlowicz P, Lewi\u0144ski A. Prolactin secretion in polycystic ovary syndrome (PCOS). Neuro Endocrinol Lett. 2015;36:53\u20138.","journal-title":"Neuro Endocrinol Lett"},{"key":"1621_CR48","doi-asserted-by":"publisher","first-page":"e2021291","DOI":"10.23750\/abm.v92i5.9866","volume":"92","author":"Z Davoudi","year":"2021","unstructured":"Davoudi Z, Araghi F, Vahedi M, Mokhtari N, Gheisari M. Prolactin level in polycystic ovary syndrome (PCOS): an approach to the diagnosis and management. Acta Biomed. 2021;92:e2021291. https:\/\/doi.org\/10.23750\/abm.v92i5.9866.","journal-title":"Acta Biomed"},{"key":"1621_CR49","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.18502\/ijrm.v19i12.10059","volume":"19","author":"E Dehghan","year":"2022","unstructured":"Dehghan E, Namiranian N, Ghadiri-Anari A, Kazem Razavi Ratki S, Azizi R. Evaluation of hyperprolactinemia risk factors in infertile women referred to Yazd Infertility Center: a cross-sectional study. Int J Reprod Biomed. 2022;19:1085\u201390. https:\/\/doi.org\/10.18502\/ijrm.v19i12.10059.","journal-title":"Int J Reprod Biomed"},{"key":"1621_CR50","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/humrep\/12.3.423","volume":"12","author":"P Aci\u00e9n","year":"1997","unstructured":"Aci\u00e9n P, Mauri M, Gutierrez M. Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms. Hum Reprod. 1997;12:423\u20139. https:\/\/doi.org\/10.1093\/humrep\/12.3.423.","journal-title":"Hum Reprod"},{"key":"1621_CR51","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/BF03347025","volume":"26","author":"M Bahceci","year":"2003","unstructured":"Bahceci M, Tuzcu A, Bahceci S, Tuzcu S. Is hyperprolactinemia associated with insulin resistance in nonobese patients with polycystic ovary syndrome? J Endocrinol Invest. 2003;26:655\u20139. https:\/\/doi.org\/10.1007\/BF03347025.","journal-title":"J Endocrinol Invest"},{"key":"1621_CR52","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33:1602\u201318. https:\/\/doi.org\/10.1093\/humrep\/dey256.","journal-title":"Hum Reprod"},{"key":"1621_CR53","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.fertnstert.2019.08.100","volume":"112","author":"EA Greenwood","year":"2019","unstructured":"Greenwood EA, Huddleston HG. Insulin resistance in polycystic ovary syndrome: concept versus cut-off. Fertil Steril. 2019;112:827\u20138. https:\/\/doi.org\/10.1016\/j.fertnstert.2019.08.100.","journal-title":"Fertil Steril"},{"key":"1621_CR54","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.fertnstert.2007.05.026","volume":"89","author":"EJ Lee","year":"2008","unstructured":"Lee EJ, Oh B, Lee JY, Kimm K, Lee SH, Baek KH. A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome. Fertil Steril. 2008;89:1213\u201320. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.05.026.","journal-title":"Fertil Steril"},{"key":"1621_CR55","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJM198812083192306","volume":"319","author":"DE Moller","year":"1988","unstructured":"Moller DE, Flier JS. Detection of an alteration in the insulin-receptor gene in a patient with insulin resistance, acanthosis nigricans, and the polycystic ovary syndrome (type A insulin resistance). N Engl J Med. 1988;319:1526\u20139. https:\/\/doi.org\/10.1056\/NEJM198812083192306.","journal-title":"N Engl J Med"},{"key":"1621_CR56","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cbi.2016.06.008","volume":"259","author":"AE S\u00f8rensen","year":"2016","unstructured":"S\u00f8rensen AE, Udesen PB, Wissing ML, Englund ALM, Dalgaard LT. MicroRNAs related to androgen metabolism and polycystic ovary syndrome. Chem Biol Interact. 2016;259:8\u201316. https:\/\/doi.org\/10.1016\/j.cbi.2016.06.008.","journal-title":"Chem Biol Interact"},{"key":"1621_CR57","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nature05482","volume":"444","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840\u20136. https:\/\/doi.org\/10.1038\/nature05482.","journal-title":"Nature"},{"key":"1621_CR58","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1210\/edrv-16-3-322","volume":"16","author":"DA Ehrmann","year":"1995","unstructured":"Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev. 1995;16:322\u201353. https:\/\/doi.org\/10.1210\/edrv-16-3-322.","journal-title":"Endocr Rev"},{"key":"1621_CR59","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37:467\u2013520. https:\/\/doi.org\/10.1210\/er.2015-1104.","journal-title":"Endocr Rev"},{"key":"1621_CR60","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1210\/endo-123-2-733","volume":"123","author":"JF Cara","year":"1988","unstructured":"Cara JF, Rosenfield RL. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology. 1988;123:733\u20139. https:\/\/doi.org\/10.1210\/endo-123-2-733.","journal-title":"Endocrinology"},{"key":"1621_CR61","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1210\/endo.141.8.7595","volume":"141","author":"G Zhang","year":"2000","unstructured":"Zhang G, Garmey JC, Veldhuis JD. Interactive stimulation by luteinizing hormone and insulin of the steroidogenic acute regulatory (StAR) protein and 17alpha-hydroxylase\/17,20-lyase (CYP17) genes in porcine theca cells. Endocrinology. 2000;141:2735\u201342. https:\/\/doi.org\/10.1210\/endo.141.8.7595.","journal-title":"Endocrinology"},{"key":"1621_CR62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000049972","volume":"55","author":"S Toprak","year":"2001","unstructured":"Toprak S, Y\u00f6nem A, Cakir B, G\u00fcler S, Azal O, Ozata M, et al. Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res. 2001;55:65\u201370. https:\/\/doi.org\/10.1159\/000049972.","journal-title":"Horm Res"},{"key":"1621_CR63","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2337\/db12-0135","volume":"62","author":"IC Yu","year":"2013","unstructured":"Yu IC, Lin HY, Liu NC, Sparks JD, Yeh S, Fang LY, et al. Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-\u03baB-mediated PTP1B expression. Diabetes. 2013;62:411\u201323. https:\/\/doi.org\/10.2337\/db12-0135.","journal-title":"Diabetes"},{"key":"1621_CR64","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/edrv.18.6.0318","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774\u2013800. https:\/\/doi.org\/10.1210\/edrv.18.6.0318.","journal-title":"Endocr Rev"},{"key":"1621_CR65","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1210\/jcem.83.6.4886","volume":"83","author":"JE Nestler","year":"1998","unstructured":"Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83:2001\u20135. https:\/\/doi.org\/10.1210\/jcem.83.6.4886.","journal-title":"J Clin Endocrinol Metab"},{"key":"1621_CR66","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1365-2605.2005.00623.x","volume":"29","author":"S Franks","year":"2006","unstructured":"Franks S, McCarthy MI, Hardy K. Development of polycystic ovary syndrome: involvement of genetic and environmental factors. Int J Androl. 2006;29:278\u201385. https:\/\/doi.org\/10.1111\/j.1365-2605.2005.00623.x.","journal-title":"Int J Androl"},{"key":"1621_CR67","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/bjp.2008.331","volume":"155","author":"Z Huang","year":"2008","unstructured":"Huang Z, Zhou X, Nicholson AC, Gotto AM Jr, Hajjar DP, Han J. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor. Br J Pharmacol. 2008;155:596\u2013605. https:\/\/doi.org\/10.1038\/bjp.2008.331.","journal-title":"Br J Pharmacol"},{"key":"1621_CR68","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/s0002-9343(01)00948-2","volume":"111","author":"RS Legro","year":"2001","unstructured":"Legro RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. Am J Med. 2001;111:607\u201313. https:\/\/doi.org\/10.1016\/s0002-9343(01)00948-2.","journal-title":"Am J Med"},{"key":"1621_CR69","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12291-008-0059-6","volume":"23","author":"S Saha","year":"2008","unstructured":"Saha S, Sarkar C, Biswas SC, Karim R. Correlation between serum lipid profile and carotid intima-media thickness in polycystic ovarian syndrome. Indian J Clin Biochem. 2008;23:262\u20136. https:\/\/doi.org\/10.1007\/s12291-008-0059-6.","journal-title":"Indian J Clin Biochem"},{"key":"1621_CR70","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1590\/1806-9282.20220854","volume":"68","author":"S G\u00fcl\u00fcc\u00fc","year":"2022","unstructured":"G\u00fcl\u00fcc\u00fc S, Can \u0130S. Total cholesterol\/high-density lipoprotein and inflammatory parameters in patients with polycystic ovary syndrome. Rev Assoc Med Bras (1992). 2022;68:1499\u2013503. https:\/\/doi.org\/10.1590\/1806-9282.20220854.","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"1621_CR71","doi-asserted-by":"publisher","first-page":"F25","DOI":"10.1016\/s0002-9149(99)00211-8","volume":"83","author":"SM Grundy","year":"1999","unstructured":"Grundy SM. Hypertriglyceridaemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999;83:F25\u20139. https:\/\/doi.org\/10.1016\/s0002-9149(99)00211-8.","journal-title":"Am J Cardiol"},{"key":"1621_CR72","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1161\/01.atv.17.1.64","volume":"17","author":"A Laws","year":"1997","unstructured":"Laws A, Hoen HM, Selby JV, Saad MF, Haffner SM, Howard BV. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status. Relation to plasma triglyceride and apolipoprotein B concentrations. Insulin resistance atherosclerosis study (IRAS) investigators. Arterioscler Thromb Vasc Biol. 1997;17:64\u201371. https:\/\/doi.org\/10.1161\/01.atv.17.1.64.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1621_CR73","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jacc.2022.10.019","volume":"81","author":"M Balling","year":"2023","unstructured":"Balling M, Afzal S, Davey Smith G, Varbo A, Langsted A, Kamstrup PR, et al. Elevated LDL triglycerides and atherosclerotic risk. J Am Coll Cardiol. 2023;81:136\u201352. https:\/\/doi.org\/10.1016\/j.jacc.2022.10.019.","journal-title":"J Am Coll Cardiol"},{"key":"1621_CR74","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ccl.2017.12.013","volume":"36","author":"A Haghikia","year":"2018","unstructured":"Haghikia A, Landmesser U. High-density lipoproteins: effects on vascular function and role in the Immune response. Cardiol Clin. 2018;36:317\u201327. https:\/\/doi.org\/10.1016\/j.ccl.2017.12.013.","journal-title":"Cardiol Clin"},{"key":"1621_CR75","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0002-9149(80)90516-0","volume":"46","author":"PW Wilson","year":"1980","unstructured":"Wilson PW, Garrison RJ, Castelli WP, Feinleib M, McNamara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham offspring study: role of lipoprotein cholesterols. Am J Cardiol. 1980;46:649\u201354. https:\/\/doi.org\/10.1016\/0002-9149(80)90516-0.","journal-title":"Am J Cardiol"},{"key":"1621_CR76","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S0022-2275(20)39245-2","volume":"7","author":"JA Glomset","year":"1966","unstructured":"Glomset JA, Janssen ET, Kennedy R, Dobbins J. Role of plasma lecithin:cholesterol acyltransferase in the metabolism of high density lipoproteins. J Lipid Res. 1966;7:638\u201348.","journal-title":"J Lipid Res"},{"key":"1621_CR77","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","volume":"86","author":"CC Kelly","year":"2001","unstructured":"Kelly CC, Lyall H, Petrie JR, Gould GW, Connell JM, Sattar N. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86:2453\u20135. https:\/\/doi.org\/10.1210\/jcem.86.6.7580.","journal-title":"J Clin Endocrinol Metab"},{"key":"1621_CR78","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1210\/jc.2004-0628","volume":"90","author":"F Orio Jr","year":"2005","unstructured":"Orio F Jr, Palomba S, Cascella T, Di Biase S, Manguso F, Tauchmanov\u00e0 L, et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:2\u20135. https:\/\/doi.org\/10.1210\/jc.2004-0628.","journal-title":"J Clin Endocrinol Metab"},{"key":"1621_CR79","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1365-2265.2012.04454.x","volume":"78","author":"N Phelan","year":"2013","unstructured":"Phelan N, O\u2019Connor A, Kyaw Tun T, Correia N, Boran G, Roche HM, et al. Leucocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance. Clin Endocrinol (Oxf). 2013;78:107\u201313. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04454.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1621_CR80","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1210\/jc.2003-031365","volume":"89","author":"HF Escobar-Morreale","year":"2004","unstructured":"Escobar-Morreale HF, Botella-Carretero JI, Villuendas G, Sancho J, San Mill\u00e1n JL. Serum interleukin-18 concentrations are increased in the polycystic ovary syndrome: relationship to insulin resistance and to obesity. J Clin Endocrinol Metab. 2004;89:806\u201311. https:\/\/doi.org\/10.1210\/jc.2003-031365.","journal-title":"J Clin Endocrinol Metab"},{"key":"1621_CR81","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1089\/gtmb.2014.0151","volume":"18","author":"S Thathapudi","year":"2014","unstructured":"Thathapudi S, Kodati V, Erukkambattu J, Katragadda A, Addepally U, Hasan Q. Tumor necrosis factor-alpha and polycystic ovarian syndrome: a clinical, biochemical, and molecular genetic study. Genet Test Mol Biomarkers. 2014;18:605\u20139. https:\/\/doi.org\/10.1089\/gtmb.2014.0151.","journal-title":"Genet Test Mol Biomarkers"},{"key":"1621_CR82","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1345\/aph.1Q514","volume":"46","author":"SM Sirmans","year":"2012","unstructured":"Sirmans SM, Weidman-Evans E, Everton V, Thompson D. Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications. Ann Pharmacother. 2012;46:403\u201318. https:\/\/doi.org\/10.1345\/aph.1Q514.","journal-title":"Ann Pharmacother"},{"key":"1621_CR83","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1055\/s-0043-104531","volume":"125","author":"DV Milutinovi\u0107","year":"2017","unstructured":"Milutinovi\u0107 DV, Nikoli\u0107 M, Veli\u010dkovi\u0107 N, Djordjevic A, Bursa\u0107 B, Nestorov J, et al. Enhanced inflammation without Impairment of Insulin Signalling in the visceral adipose tissue of 5\u03b1-Dihydrotestosterone-Induced Animal Model of Polycystic Ovary Syndrome. Exp Clin Endocrinol Diabetes. 2017;125:522\u20139. https:\/\/doi.org\/10.1055\/s-0043-104531.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"1621_CR84","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0014-5793(89)80476-4","volume":"242","author":"JV Castell","year":"1989","unstructured":"Castell JV, G\u00f3mez-Lech\u00f3n MJ, David M, Andus T, Geiger T, Trullenque R, et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989;242:237\u20139. https:\/\/doi.org\/10.1016\/0014-5793(89)80476-4.","journal-title":"FEBS Lett"},{"key":"1621_CR85","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1172\/JCI117495","volume":"94","author":"GS Hotamisligil","year":"1994","unstructured":"Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J Clin Invest. 1994;94:1543\u20139. https:\/\/doi.org\/10.1172\/JCI117495.","journal-title":"J Clin Invest"},{"key":"1621_CR86","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1210\/edrv-11-3-454","volume":"11","author":"EY Adashi","year":"1990","unstructured":"Adashi EY. The potential relevance of cytokines to ovarian physiology: the emerging role of resident ovarian cells of the white blood cell series. Endocr Rev. 1990;11:454\u201364. https:\/\/doi.org\/10.1210\/edrv-11-3-454.","journal-title":"Endocr Rev"},{"key":"1621_CR87","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1161\/01.cir.103.22.2717","volume":"03","author":"R Poddar","year":"2001","unstructured":"Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation. 2001;03:2717\u201323. https:\/\/doi.org\/10.1161\/01.cir.103.22.2717.","journal-title":"Circulation"},{"key":"1621_CR88","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/humupd\/dms059","volume":"19","author":"M Murri","year":"2013","unstructured":"Murri M, Luque-Ram\u00edrez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19:268\u201388. https:\/\/doi.org\/10.1093\/humupd\/dms059.","journal-title":"Hum Reprod Update"},{"key":"1621_CR89","doi-asserted-by":"publisher","first-page":"e11110","DOI":"10.7759\/cureus.11110","volume":"12","author":"V Kondapaneni","year":"2020","unstructured":"Kondapaneni V, Gutlapalli SD, Poudel S, Zeb M, Toulassi IA, Cancarevic I. Significance of homocysteine levels in the management of polycystic ovarian syndrome: a Literature Review. Cureus. 2020;12:e11110. https:\/\/doi.org\/10.7759\/cureus.11110.","journal-title":"Cureus"},{"key":"1621_CR90","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/01.atv.0000035404.18281.37","volume":"22","author":"G Wang","year":"2002","unstructured":"Wang G, Woo CW, Sung FL, Siow YL. Increased monocyte adhesion to aortic endothelium in rats with hyperhomocysteinaemia: role of chemokine and adhesion molecules. Arterioscler Thromb Vasc Biol. 2002;22:1777\u201383. https:\/\/doi.org\/10.1161\/01.atv.0000035404.18281.37.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1621_CR91","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.2337\/diacare.24.8.1403","volume":"24","author":"JB Meigs","year":"2001","unstructured":"Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care. 2001;24:1403\u201310. https:\/\/doi.org\/10.2337\/diacare.24.8.1403.","journal-title":"Diabetes Care"},{"key":"1621_CR92","doi-asserted-by":"publisher","first-page":"9583","DOI":"10.1074\/jbc.M112.431627","volume":"288","author":"Y Li","year":"2013","unstructured":"Li Y, Zhang H, Jiang C, Xu M, Pang Y, Feng J, et al. Hyperhomocysteinaemia promotes insulin resistance by inducing endoplasmic reticulum stress in adipose tissue. J Biol Chem. 2013;288:9583\u201392. https:\/\/doi.org\/10.1074\/jbc.M112.431627.","journal-title":"J Biol Chem"},{"key":"1621_CR93","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1161\/CIRCRESAHA.112.269472","volume":"111","author":"D Zhang","year":"2012","unstructured":"Zhang D, Fang P, Jiang X, Nelson J, Moore JK, Kruger WD, et al. Severe hyperhomocysteinaemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr\/CBS-deficient mice. Circ Res. 2012;111:37\u201349. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.269472.","journal-title":"Circ Res"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01621-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01621-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01621-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:41:49Z","timestamp":1740030109000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-025-01621-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,20]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1621"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01621-6","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,20]]},"assertion":[{"value":"26 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that there are no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}}],"article-number":"34"}}